Stock UniverseDerived research view · source repositories remain read-only

Maravai LifeSciences Holdings, Inc. (MRVI)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
39.58
Global Rank
457
Market Cap
915.16M
Latest Close
5.02
RS Composite
29.66% · G#298

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
27.41%
3M
41.41%
6M
43.02%
1Y
127.15%
3Y
-60.90%
5Y
-86.63%
10Y
-83.18%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.26M · 30-day average: 2.72M · Max drawdown over stored range: -97.16%

Research Snapshot

Relative Strength vs SPX

RS Composite29.66%
20D RS26.78%
60D RS32.44%
120D RS28.31%
Global RS Rank298 · 91.12% percentile
Qualified+ RS Rank125 · 90.06% percentile
Group ScopeQualified+
Primary RS Rank48 · 89.52% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank49 / 701
Primary Percentile93.15
Score Notesmarket-cap support, industry-tailwind, innovation-keyword, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-08204.73Mn/a-168.26M-104.56M-0.72-68.56M25.70M-94.26M145Mn/a-82.19%-51.07%-33.49%-46.04%165.92M235.57M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-0.72-7.0x$1.413.6x$-0.65-7.7x$-0.47-10.6x

Shares Diluted: 145M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue284.098799.24883.001288.945259.185185.743
Revenue Growth (YoY)98.476%181.325%10.48%-67.277%-10.3%-28.336%
Gross Profit204.449658.679714.044140.202108.30935.69
Operating Income103.781543.396569.916-24.368-72.683-125.63
Free Cash Flow126.779353.72518.88760.671-22.193-70.722
Free Cash Flow Per Share4.3861.3722.0320.46-0.161-0.49
EPS (Diluted) GAAP2.3552641.5607111.669555-0.902288-1.050324-0.905881
EPS Growth9300%-33.735%6.974%9300%9300%
EPS Non-GAAP
Gross Margin71.964%82.413%80.866%48.522%41.788%19.215%
Operating Margin36.53%67.989%64.543%-8.433%-28.043%-67.636%
Profit Margin27.064%22.776%24.938%-41.194%-55.885%-70.405%
Free Cash Flow Margin44.625%44.257%58.764%20.997%-8.563%-38.075%
Shares Outstanding (Diluted)28.908257.803255.323131.919137.906144.36
Shares Change (YoY)-88.615%791.805%-0.962%-48.333%4.538%4.68%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-0865.84M51.19%-2.16M-3.28%-3.73M-5.67%-0.02146.43M165.92M235.57Mprocessed
2025 Q42026-02-2649.87M25.75%-58.80M-1.18%-35.68M-71.55%-0.25145.08M216.89M286.33Mprocessed
2025 Q32025-11-0741.63M13.58%-41.03M-98.56%-25.56M-61.39%-0.18144.68M243.57M287.38Mprocessed
2025 Q22025-08-1147.40Mn/a-66.28M-1.40%-39.59M-83.53%-0.27144.24M269.91M288.44Mprocessed
2025 Q12025-05-1246.85Mn/a-49.16M-1.05%-29.95M-63.92%-0.21143.43M285.05M289.50Mprocessed
2024 Q42025-03-1856.41Mn/a-38.13M-67.60%-26.14M-46.35%-0.18141.84M322.40M290.49Mprocessed
2024 Q32024-11-1265.20Mn/a-169.11M-2.59%-99.04M-1.52%-0.70141.56M578.16M516.28Mprocessed
2024 Q22024-08-0873.40Mn/a-9.51M-12.96%-7.58M-10.33%-0.05135.84M573.17M517.08Mprocessed
2024 Q12024-05-0964.18Mn/a-18.86M-29.39%-12.08M-18.82%-0.09132.33M561.69M517.89Mprocessed
2023 Q42024-02-2974.14Mn/a-7.15M-9.64%-105.96M-1.43%-0.80132.14M574.96M518.71Mprocessed
2023 Q32023-11-0866.86Mn/a-15.42M-23.06%-6.46M-9.66%-0.05131.93M579.61M519.52Mprocessed
2023 Q22023-08-0868.91Mn/a-11.61M-16.85%-6.54M-9.49%-0.05131.86M580.18M520.34Mprocessed
2023 Q12023-05-0979.03Mn/a2.53M3.21%-67.00K-0.08%-0.00131.74M628.27M521.16Mprocessed
2022 Q42023-02-28204.71Mn/a109.25M53.37%37.63M18.38%0.15255.32M551.27M522.00Mprocessed
2022 Q32022-11-04191.26Mn/a116.90M61.12%44.47M23.25%0.34131.65M617.45M522.82Mprocessed
2022 Q22022-08-05242.73Mn/a180.70M74.44%71.24M29.35%0.53255.36M550.68M523.65Mprocessed
2022 Q12022-05-06244.29Mn/a167.37M68.51%66.86M27.37%0.50255.29M431.47M524.50Mprocessed
2021 Q42022-03-01228.44Mn/a151.09M66.14%55.44M24.27%0.22257.81M236.18M524.59Mprocessed
2021 Q32021-11-15204.81Mn/a156.87M76.59%54.27M26.50%0.45258.03M547.90M525.58Mprocessed
2021 Q22021-08-11217.78Mn/a154.25M70.83%49.08M22.53%0.44112.28M374.71M526.58Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.